1 Min Read
July 7(Reuters) - Solasia Pharma KK
* Says it obtained the marketing approval of episil®(SP-03), in Japan, on July 6
Source text in Japanese:goo.gl/tMDSrV
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.